science

Previous research has focused more on homing in on a target or tailoring a vaccine specific to a patient's own cancer profile.

"This study suggests a third emerging paradigm," said study co-author Duane Mitchell, MD. "What we found is by using a vaccine designed not to target cancer specifically but rather to stimulate a strong immunologic response, we could elicit a very strong anticancer reaction. And so this has significant potential to be broadly used across cancer patients – even possibly leading us to an off-the-shelf cancer vaccine."

So... Kinda triggering your own auto-inmune response. But I'd be wary of trouble with overtly aggressive auto-inmune responses, as we already have quite a few diseases coming from these, as well.